12:00 AM
 | 
Feb 06, 2012
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Teva sales and marketing update

Teva subsidiary Cephalon Inc. said it is recalling lot TB30111 of 25 mg vials of IV

Read the full 80 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >